Alexandria Company for Pharmaceuticals and Chemical Industries (AXPH) Revenue
Revenue
EGP 1.02B
Fiscal year 2020
Revenue (also called sales or turnover) is the total income a company generates from its core business before any costs or expenses are deducted. For EGX-listed companies it is reported in the annual income statement in Egyptian pounds.
Revenue history
| Fiscal year | Revenue | YoY growth |
|---|---|---|
| 2020 | 1.02B | 23.52% |
| 2019 | 829.04M | 16.97% |
| 2018 | 708.79M | 37.11% |
| 2017 | 516.94M | 21.64% |
| 2016 | 424.96M | 10.99% |
| 2015 | 382.89M | 22.79% |
| 2014 | 311.83M | 6.58% |
| 2013 | 292.58M | 9.76% |
| 2012 | 266.57M | 16.03% |
| 2011 | 229.75M | 7.05% |
| 2010 | 214.61M | 3.82% |
| 2009 | 206.72M | -3% |
| 2008 | 213.12M | 2.36% |
| 2007 | 208.22M | -1.74% |
| 2006 | 211.9M | — |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.